QA: Ensysce Biosciences Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001716947_2025_Ensysce_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0001716947, Ensysce Biosciences Inc

  xvar xval
0 AssetsCurrent 5,344,682
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 252,550
4 LiabilitiesCurrent 2,207,197
5 LiabilitiesNoncurrent 10,096
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,909,079
9 ResearchAndDevelopmentExpense 7,298,700
10 remainder_Expenses 0
11 remainder_Revenues 4,512,198
12 remainder_NetIncome -795,950
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,597,232
1 Liabilities 2,217,293
2 Expenses 12,207,779
3 Revenues 4,512,198
4 StockholdersEquity 3,379,939
5 NetIncome -8,491,531
6 ComprehensiveNetIncome -8,491,531
7 BaseVar 12,665,226
8 EconomicCapitalRatiobeforeLimitedLiability -0.287
9 EconomicCapitalRatio 1.40

Edgar->Model Mapping

Feature Distribution

Change over Time